These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31825388)

  • 21. Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease.
    Austgen G; Marsh L
    Prog Brain Res; 2022; 269(1):59-90. PubMed ID: 35248207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological characteristics of Parkinson's disease].
    Ostrosky-Solis F
    Rev Neurol; 2000 Apr 16-30; 30(8):788-96. PubMed ID: 10893746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease.
    Madhyastha TM; Askren MK; Zhang J; Leverenz JB; Montine TJ; Grabowski TJ
    Brain; 2015 Sep; 138(Pt 9):2672-86. PubMed ID: 26173859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of systemic oxidative stress and mesial temporal network degeneration in Parkinson's disease with and without cognitive impairment.
    Chiang PL; Chen HL; Lu CH; Chen YS; Chou KH; Hsu TW; Chen MH; Tsai NW; Li SH; Lin WC
    J Neuroinflammation; 2018 Sep; 15(1):281. PubMed ID: 30257698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
    Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
    Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Social cognitive function in neurodegenerative diseases].
    Chimagomedova AS; Lyashenko EA; Babkina OV; Iakovleva OV; Vasenina EE; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):168-173. PubMed ID: 29265104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theory of mind in Parkinson's disease: A meta-analysis.
    Bora E; Walterfang M; Velakoulis D
    Behav Brain Res; 2015 Oct; 292():515-20. PubMed ID: 26166188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study.
    Valldeoriola F; Salvador A; Gómez-Arguelles JM; Marey J; Moya M; Ayuga Á; Ramírez F
    Int J Neurosci; 2018 Apr; 128(4):369-375. PubMed ID: 29249180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social inappropriateness in neurodegenerative disorders.
    Desmarais P; Lanctôt KL; Masellis M; Black SE; Herrmann N
    Int Psychogeriatr; 2018 Feb; 30(2):197-207. PubMed ID: 28689508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfaction deterioration in cognitive disorders in the elderly.
    Ottaviano G; Frasson G; Nardello E; Martini A
    Aging Clin Exp Res; 2016 Feb; 28(1):37-45. PubMed ID: 26003671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.
    Marras C; Tröster AI; Kulisevsky J; Stebbins GT
    Mov Disord; 2014 Apr; 29(5):584-96. PubMed ID: 24757108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theory of Mind in normal ageing and neurodegenerative pathologies.
    Kemp J; Després O; Sellal F; Dufour A
    Ageing Res Rev; 2012 Apr; 11(2):199-219. PubMed ID: 22186031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance.
    Calabresi P; Picconi B; Parnetti L; Di Filippo M
    Lancet Neurol; 2006 Nov; 5(11):974-83. PubMed ID: 17052664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social Cognition Dysfunctions in Neurodegenerative Diseases: Neuroanatomical Correlates and Clinical Implications.
    Christidi F; Migliaccio R; Santamaría-García H; Santangelo G; Trojsi F
    Behav Neurol; 2018; 2018():1849794. PubMed ID: 29854017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are non-demented patients with Parkinson's disease able to decide about their own treatment?
    Eygelshoven S; van den Hout A; Tucha L; Fuermaier ABM; Bangma DF; Thome J; Lobbestael J; Tucha O; Koerts J
    Parkinsonism Relat Disord; 2017 May; 38():48-53. PubMed ID: 28262511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive function assessment in idiopathic Parkinson's disease.
    Piovezan MR; Teive HA; Piovesan EJ; Mader MJ; Werneck LC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):942-6. PubMed ID: 18094850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.
    Zgaljardic DJ; Foldi NS; Borod JC
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1287-301. PubMed ID: 15480839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.